Cambridge Epigenetix's Series C Round

Cambridge Epigenetix raised a round of funding on May 09, 2018.

Cambridge Epigenetix is commercializing a novel technology that pioneers quantitative single-base resolution sequencing of the methylated bases 5-hmC and 5-mC leading to substantially more accurate de…

Articles about Cambridge Epigenetix's Series C Round: